Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-019805
Filing Date
2016-05-12
Accepted
2016-05-12 18:38:52
Documents
1
Period of Report
2016-05-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3371
  Complete submission text file 0000899243-16-019805.txt   4771
Mailing Address C/O JAVELIN PHARMACEUTICALS, INC. 125 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address
Driscoll Martin J (Reporting) CIK: 0001339402 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37718 | Film No.: 161645344

Mailing Address 113 CEDAR STREET SUITE 7 MILFORD MA 01757
Business Address 113 CEDAR STREET SUITE 7 MILFORD MA 01757 508-473-5993
Spring Bank Pharmaceuticals, Inc. (Issuer) CIK: 0001566373 (see all company filings)

EIN.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations